Figure 1: Distribution and phenotype of slanDCs in human tonsils. | Nature Communications

Figure 1: Distribution and phenotype of slanDCs in human tonsils.

From: slanDCs selectively accumulate in carcinoma-draining lymph nodes and marginate metastatic cells

Figure 1

Sections are from representative FFPE human tonsils and are stained as indicated by labels (CKP, pan-cytokeratin; LYS, lysozyme). (a) DD2+ slanDCs surround the CKP+ epithelium of tonsil crypts and mostly appear as large and stellate cells (b) (n=10). (c) Flow cytometry analysis was performed on live CD45+/HLA-DR+-singlet cells from CD3+/CD19+- depleted tonsil cell suspensions. The panel shows the gating strategy used to identify CD141+DCs (blue gate), CD1c+DCs (orange gate), CD14high MΦ (grey gate) and slanDCs (purple gate), within the HLA-DR+/CD11c+ cells. By the same strategy, pDCs were identified within the HLA-DR+/CD11c cells (green gate). A representative experiment out of three ones performed with similar results is shown. (d) Bar graph shows the percentage of each DC subset and macrophages within the HLA-DR+ cells (mean±s.d.; n=5). (e) The histogram shows the relative expression of M-DC8 by each DC and MΦ populations. Data are representative of similar results obtained from five tonsil preparations. (fm) Panels show representative DD2+ slanDCs co-stained with antibodies towards a set of markers (n=10), as labeled. Sections are counterstained with Meyer’s haematoxylin. Original magnifications: 40X (a, scale bar, 500 μm); 400X (b,fm, scale bar, 50 μm).

Back to article page